(Chelsea Update would like to thank Laura Blodgett for the information in this press release.)
Saint Joseph Mercy Health System (SJMHS) Michigan Cancer Research Consortium (MCRC) has been awarded a grant for more than $10 million as part of the National Cancer Institute’s Community Oncology Research Program (NCORP), a national network of organizations that provide cancer care to diverse populations in community-based healthcare practices across the United States.
All of the grant dollars will be used to fund infrastructure and staff to assist patients to participate in more than 120 clinical trials that are available. St. Joseph Mercy Chelsea is one of the participating locations.
For more information including a list of current clinical trials, call 734-712-5658 or click here.
“For patients to be able to take part in the highest quality research treatments right in their own communities is a tremendous opportunity,” said Philip Stella, MD, principal investigator, Michigan Cancer Research Consortium, Saint Joseph Mercy Health System.
“At the same time, we are assisting the National Cancer Institute to increase their access to real world health care delivery in the community, where the majority of cancer patients receive their care,” he said in a press release.
MCRC was selected as one of 34 community sites across the country to receive the 5-year NCORP grant enabling patients throughout the 13-hospital consortium to participate in cutting-edge clinical trials offering access to the top cancer treatments available.
